Pfizer and BioNTech to submit to FDA today for emergency authorization for their coronavirus vaccine
Pfizer and BioNTech to submit to FDA today for emergency authorization for their coronavirus vaccine

After announcing their coronavirus vaccine candidate was 95% effective, Pfizer planned to file for the FDA’s emergency use authorization.